This map shows the geographic impact of MI Ruoran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MI Ruoran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MI Ruoran more than expected).
This network shows the impact of papers produced by MI Ruoran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MI Ruoran. The network helps show where MI Ruoran may publish in the future.
Co-authorship network of co-authors of MI Ruoran
This figure shows the co-authorship network connecting the top 25 collaborators of MI Ruoran.
A scholar is included among the top collaborators of MI Ruoran based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with MI Ruoran. MI Ruoran is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Ruoran, MI, et al.. (2017). Application of combined intraperitoneal and intravenous neoadjuvant chemotherapy in senile patients with advanced ovarian cancer and massive ascites.. PubMed. 38(2). 209–213.4 indexed citations
3.
Liu, Zheng, et al.. (2015). Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways.. PubMed. 8(11). 20565–72.97 indexed citations
Liu, Guozhong, Liming Yu, Haiyan Song, MI Ruoran, & Yaqiong Chen. (2014). [Clinical value of human papillomavirus genotyping testing in the diagnosis of cervical intraepithelial neoplasia].. PubMed. 49(6). 446–50.1 indexed citations
Liu, Guoyan, et al.. (2008). [Relationship between nucleotide excision repair gene ERCC1 and resistance to cisplatin in ovarian cancer].. PubMed. 30(3). 184–7.7 indexed citations
9.
Liu, Guoyan, et al.. (2008). [Influence of mifepristone on DNA repair genes and cisplatin sensitivity in human ovarian cancer drug-resistance cells].. PubMed. 43(2). 132–5.2 indexed citations
Ruoran, MI. (2006). Study on the Expressions of Vascular Endothelial Growth Factor and Its Receptors and Matrix Metalloproteinase 9 in Epithelial Ovarian Cancer.1 indexed citations
12.
Liu, Guoyan, et al.. (2006). [Enhanced cisplatin cytotoxicity by RNA interfering the excision repair cross-complementing 1 gene in ovarian cancer cell lines].. PubMed. 41(5). 339–42.5 indexed citations
13.
Ruoran, MI, et al.. (2004). Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.. PubMed. 117(10). 1547–51.12 indexed citations
14.
Ruoran, MI, et al.. (2004). [Effect of luteinized granulosa cell conditioned medium on cortical granule of mouse oocytes matured in vitro].. PubMed. 39(11). 747–9.2 indexed citations
Yuan, Bibo & MI Ruoran. (2002). [Antisense oligodeoxynucleotides of human telomerse catalytic sub-unit inhibits telomerase activity and proliferation in SKOV3 and COC1].. PubMed. 37(4). 198–201.1 indexed citations
17.
Ruoran, MI, et al.. (2002). [In vitro study on hormonal regulation of human endometrial stroma cell decidualization].. PubMed. 37(8). 475–7.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.